Eris Lifesciences Q1 Results
- BSE: 540596
- NSE: ERIS
- ISIN: INE406M01024
- Sector: Biotechnology & Drugs
BSE
1,708.20
-26.80 (-1.54%)
-26.80 (-1.54%)Volume5.46 K
Updated: Tue 8 Jul, 2025 | 15:29:00
NSE
1,714.00-20.00 (-1.15%)
-20.00 (-1.15%)Volume86.37 K
Updated: Tue 8 Jul, 2025 | 15:30:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Eris Lifesciences Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Mar 25 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 545.67 | 530.75 | 19.56% |
| Depreciation/ Amortization | 75.94 | 77.84 | 40.89% |
| Operating Income | 174.05 | 174.55 | 84.12% |
| Net Income | 83.18 | 93.45 | 17.22% |
| Other Operating Expenses Total | 156.52 | 161.21 | -13.92% |
| Net Income Before Taxes | 115.32 | 128.28 | 50.46% |
| Total Revenue | 719.72 | 705.30 | 30.64% |
| Selling/ General/ Admin Expenses Total | 132.62 | 121.45 | 29.42% |
| Diluted Normalized EPS | 6.10 | 6.85 | 16.97% |